Medical Treatment of Cancer
Immediately after diagnosis, it is essential to carefully plan a cancer treatment that is specific to the individual. Factors that affect the success of cancer treatment include the timing of surgery, personalized treatment plan, and the appropriate timing and completion of chemotherapy or radiation therapy.
Only using alternative treatments for cancer leads to a shorter lifespan for cancer patients (1).
The most successful results in cancer are obtained by combining modern medical cancer treatment with scientifically proven complementary therapies (2, 3, 4).
Medical options for cancer treatment:
- Surgery
- Chemotherapy
- Radiation therapy
- Immunotherapies
- Cancer vaccines
- Targeted therapies
- Bone marrow transplantion
- Personalized treatment
- Invasive treatments
- Radionuclide therapies
- Hormonal therapies
The main goal of Prof Dr. Canfeza Sezgin Medical & Complementary Cancer Treatment Clinic is to plan cancer treatments in a personalized way that results in fewer side effects and better outcomes. To achieve this goal, modern cancer treatments are combined with complementary therapies that have scientific validity.
Reference:
- Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. J Natl Cancer Inst. 2018 Jan 1;110(1).
- Li SG, Chen HY, Ou-Yang CS, Wang XX, Yang ZJ, Tong Y, Cho WC. The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis. PLoS One. 2013;8(2):e57604.
- Hung KF, Hsu CP, Chiang JH, Lin HJ, Kuo YT, Sun MF, Yen HR. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017 Mar 6;199:168-174.
- Issels RD, Lindner LH, Verweij J, et al. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA Oncol. 2018;4(4):483-492.
